Cardiovascular and noncardiovascular mortality among patients starting dialysis.
about
Antiplatelet agents for chronic kidney diseaseHigh-flux versus low-flux membranes for end-stage kidney diseaseAntiplatelet agents for chronic kidney diseaseInterventions for lowering plasma homocysteine levels in dialysis patientsNonadherence to Medication Therapy in Haemodialysis Patients: A Systematic ReviewPrognostic effect of high-flux hemodialysis in patients with chronic kidney diseaseLowering cholesterol in chronic kidney disease: is it safe and effective?Predictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start HemodialysisThe association of mid-regional pro-adrenomedullin and mid-regional pro-atrial natriuretic peptide with mortality in an incident dialysis cohortYounger black patients have a higher risk of infection mortality that is mostly non-dialysis related: A national study of cause-specific mortality among U.S. maintenance dialysis patients.Speckle tracking echocardiography detects uremic cardiomyopathy early and predicts cardiovascular mortality in ESRD.Left ventricular diastolic dysfunction in dialysis patients assessed by novel speckle tracking strain rate analysis: prevalence and determinantsMagnitude of discordance between registry data and death certificate when evaluating leading causes of death in dialysis patients.Trends in in-hospital cardiopulmonary resuscitation and survival in adults receiving maintenance dialysis.Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011.Prevalence of intestinal parasitism and associated symptomatology among hemodialysis patients.Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study.Single nucleotide variants in the protein C pathway and mortality in dialysis patientsEffect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.Biology of sepsis: its relevance to pediatric nephrology.The pattern of choosing dialysis modality and related mortality outcomes in Korea: a national population-based study.Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilationp-Cresol and cardiovascular risk in mild-to-moderate kidney diseaseCentral pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study.Multisystemic engagement and nephrology based educational intervention: a randomized controlled trial protocol on the KidneyTteam At Home study.Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patientsEffects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: a retrospective cohort study.Association of versican turnover with all-cause mortality in patients on haemodialysis.Why do young people with chronic kidney disease die early?Low health literacy associates with increased mortality in ESRD.Gout and subsequent increased risk of cardiovascular mortality in non-diabetics aged 50 and above: a population-based cohort study in Taiwan.Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solutionPrognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan.The colon: an overlooked site for therapeutics in dialysis patients.Are non-cardiac surgeries safe for dialysis patients? - A population-based retrospective cohort studyShould we still focus that much on cardiovascular mortality in end stage renal disease patients? The CONvective TRAnsport STudy.Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.Predictive value of echocardiographic parameters for clinical events in patients starting hemodialysis.Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators
P2860
Q24197614-620276A4-10A4-4BC6-A662-C63916D65A86Q24200387-65F1EFF1-4E21-48B4-A98B-73F5C52B91D2Q24200752-743434E5-EC94-4F73-8A3D-70D2B2F17E44Q26471859-6CE521A1-AD1E-4631-A23D-F1A4154E0229Q26774337-EBCE5C09-81C1-4BC0-91A1-C485A0391C11Q26775524-C82295FC-4964-4F11-BF45-DF5E47CAE417Q28083502-4C6AE081-8362-43CD-9A08-2C0E5BEC16B2Q28468444-330177D6-E9EF-4CAD-AD52-D5D6A70BBBEDQ28742141-9489B0D9-BDE7-431D-ABC8-0D5362496240Q30276101-FE48A0C1-37BE-492B-A63F-47C0278914D7Q30401905-ADF2C8EB-1990-4DCF-AD4D-BC31D6655E36Q30467327-DEA60E7D-1701-4A44-8C2A-395A9D23E972Q30607332-C49320C9-2ECE-43DE-A37A-B5534F1489AFQ30652621-E08FEA69-8E3C-4BC3-901B-0ECD8CACDDE4Q30764638-F5F7F115-DAE3-4521-8AF0-603D865C6D91Q33457593-3339535D-053F-4EC6-A0DA-F516FBA13E79Q33584964-5BE7A2BB-54B5-4EE1-8C4F-FF6B8AEA22ABQ33591571-C55BFDD9-6930-4A66-8122-176967C3542DQ33623532-049AB98F-E075-456A-BC20-720E80F5FA31Q33882451-2217A3E3-4818-4D28-9E53-9BF0FB0C8051Q33907284-12DF6899-B437-492B-BC81-4E2674ECEB03Q33944773-CD15267B-064C-4E4A-B7C6-04CBCF1C2BC6Q33944858-CE2AD621-5054-4DCC-BB5D-314C32751F9BQ34139955-09CA1CE1-1B1C-45D1-B7EC-74B6CF26A8FDQ34348532-01F64DFC-8A54-40DE-926D-419CE7C97F27Q34362687-B1D75740-B675-4408-A204-A185A29369F8Q34391966-AB4C27C0-1C8B-4B44-9817-B1463E7450E6Q34420828-091479E1-79C9-4E86-9A30-E9D3CC97EC21Q34453230-FCBD0F69-FAAC-4982-B9B0-D7087E05AC57Q34457095-3C9D2534-B147-468D-9547-50ACDDAB30D4Q34484081-069605E5-FE7F-4534-9081-81B5BBB1DA44Q34505567-72B9C8C4-B7C9-41B2-A1E9-458EEE910426Q34549739-E493CB94-B9D0-4B39-A16D-0A425035DF50Q34607428-044A6B02-49B0-40B2-8A5D-C018FEE62AF3Q34630192-08E37C81-E3DA-4835-BFBC-46E088F13238Q34688676-21D6AF0C-5CB3-4EA7-9020-AC38BD0881CCQ34751855-ED427A13-64DE-4E03-89C9-EBDF53AC0F04Q34779472-1C519227-7A10-4B12-B4C2-6C9EAC942B49Q34784711-69CB2F36-05BB-4AA2-98FA-D8FA797CB758Q34785990-EBB1A237-EB51-4C4B-8197-F4F6A5C67881
P2860
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
@en
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
@nl
type
label
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
@en
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
@nl
prefLabel
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
@en
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
@nl
P2093
P921
P356
P1476
Cardiovascular and noncardiovascular mortality among patients starting dialysis.
@en
P2093
David Ansell
Diana C Grootendorst
Dinanda J de Jager
Frederic Collart
Frits R Rosendaal
Jack F M Wetzels
James G Heaf
Johan De Meester
Kitty J Jager
Lonneke M J Tomas
P304
P356
10.1001/JAMA.2009.1488
P407
P577
2009-10-01T00:00:00Z